UBS Group AG - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 63 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,867,672
+75.2%
68,551
+43.0%
0.00%
Q2 2023$1,066,310
+43.0%
47,924
+39.2%
0.00%
Q1 2023$745,776
+17.2%
34,431
+9.9%
0.00%
Q4 2022$636,211
-25.2%
31,325
-5.5%
0.00%
Q3 2022$850,000
+11.3%
33,151
+3.1%
0.00%
Q2 2022$764,000
-86.0%
32,156
-86.8%
0.00%
-100.0%
Q1 2022$5,472,000
+15.3%
242,991
+1.4%
0.00%
+100.0%
Q4 2021$4,744,000
+540.2%
239,576
+537.0%
0.00%
Q3 2021$741,000
-66.8%
37,612
-62.9%
0.00%
-100.0%
Q2 2021$2,232,000
+125.7%
101,432
+144.0%
0.00%
Q1 2021$989,000
-7.7%
41,569
+1.5%
0.00%
Q4 2020$1,072,000
+46.6%
40,948
-2.5%
0.00%
Q3 2020$731,000
-67.1%
42,000
-68.3%
0.00%
-100.0%
Q2 2020$2,225,000
-41.1%
132,304
-58.3%
0.00%
-50.0%
Q1 2020$3,776,000
-5.5%
317,583
-3.8%
0.00%
+100.0%
Q4 2019$3,996,000
+83.4%
330,217
+114.2%
0.00%0.0%
Q3 2019$2,179,000
+29.3%
154,183
+2.0%
0.00%0.0%
Q2 2019$1,685,000
+110.4%
151,109
+121.5%
0.00%
Q1 2019$801,000
-43.7%
68,218
-35.9%
0.00%
-100.0%
Q4 2018$1,422,000
+70.3%
106,412
+78.6%
0.00%
Q3 2018$835,000
-44.6%
59,565
-37.8%
0.00%
-100.0%
Q2 2018$1,506,000
+66.2%
95,802
+73.9%
0.00%
Q1 2018$906,000
-14.4%
55,087
-6.0%
0.00%
Q4 2017$1,058,000
-28.1%
58,588
-23.1%
0.00%
-100.0%
Q3 2017$1,471,000
+88.8%
76,227
+15.4%
0.00%
Q2 2017$779,000
+3.3%
66,074
-3.9%
0.00%
Q1 2017$754,000
+26.5%
68,770
-16.3%
0.00%
Q4 2016$596,000
+28.4%
82,167
+15.2%
0.00%
Q3 2016$464,000
-46.0%
71,318
-54.7%
0.00%
-100.0%
Q2 2016$859,000
+63.3%
157,328
+40.0%
0.00%
Q1 2016$526,000
-22.3%
112,388
-17.4%
0.00%
Q4 2015$677,000
+60.8%
136,000
+21.3%
0.00%
Q3 2015$421,000
-36.9%
112,112
+1.1%
0.00%
Q2 2015$667,000
-3.1%
110,944
-9.6%
0.00%
Q1 2015$688,000
+70.7%
122,749
-8.8%
0.00%
Q4 2014$403,000134,5780.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders